packagePomalidomide

pomalidomide

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Pomalidomide is an immunomodulating and anti-angiogenic medicine used to treat multiple myeloma, and has also been studied for conditions such as amyloidosis, myelofibrosis, and plasma cell leukemia. It is approved and authorised in the European Union, where several pomalidomide products are on the market.

Summary written by glm-5.3-flash from Wikidata Q7227206 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:pomalidomide
ATC codes:L04AX06
DrugBank:DB08910
PubChem CID:134780
ChEBI:72690
Wikidata:Q7227206
formula:C13H11N3O4
molar mass:273.248 g/mol (PubChem CID 134780)
logP:0.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown